LunaDNA Community Health Research Platform
Member-owned health data sharing platform for research participation
Platform · Cloud SaaSCompany source
Company profile
About LunaDNA
LunaDNA operates a community-owned health and DNA data platform that empowers individuals to contribute their health and genetic information to medical research while retaining ownership of their data. The company's platform enables members to share their health data, DNA information, and other medical records with researchers and pharmaceutical companies in a secure, consent-based environment. LunaDNA's unique model allows participants to become shareholders in the platform, creating a community where members benefit directly from the value their data generates. The platform facilitates precision medicine research by aggregating diverse health datasets that researchers can access with explicit participant consent. By combining genomic data with longitudinal health information, LunaDNA supports studies aimed at understanding disease mechanisms, developing targeted therapies, and advancing personalized medicine. The company serves researchers, pharmaceutical companies, and biotechnology firms seeking access to consented, high-quality health data while prioritizing participant privacy, data security, and equitable benefit-sharing.
Company description LunaDNA official website
Primary marketPrecision Medicine & Genomics
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at LunaDNA?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
- Biotechnology firms
- Pharmaceutical companies
- Researchers
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Caregiver perspectives on disease burden and treatment priorities in KCNT1-related disorders.Epilepsy & behavior : E&B · Aug 1, 2026
Database shares that transform research subjects into partners.Nature biotechnology · Oct 1, 2019
Importance of Participant-Centricity and Trust for a Sustainable Medical Information Commons.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · Mar 1, 2019
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from LunaDNA
Recent articles published on LunaDNA's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Precision Medicine & Genomics
Companies using AI to analyze genomic, proteomic, metabolomic, or multi-omics data to provide personalized treatment recommendations, identify genetic risks, or develop targeted therapies. Includes genomic sequencing platforms with AI analysis, preventive medicine based on genetic risk assessment, and longevity care based on molecular and genetic data.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.